Gallstones After Bariatric Surgery: Prevention with UDCA
- Why bariatric surgery increases gallstone risk
- How common are gallstones after weight loss surgery?
- Who is at highest risk?
- Ursodeoxycholic acid (UDCA) – the proven prevention
- UDCA dosing, duration, and side effects
- Prophylactic cholecystectomy – when is it recommended?
- Managing gallstones after bariatric surgery
- Interactive FAQ – 9 common questions
Why bariatric surgery increases gallstone risk
Bariatric surgery (gastric bypass, sleeve gastrectomy, gastric banding) leads to rapid weight loss, which paradoxically increases the risk of gallstones. The mechanisms are well understood:
- Rapid mobilisation of cholesterol: Adipose tissue releases large amounts of cholesterol, which is secreted into bile, causing supersaturation.
- Gallbladder stasis: Very low calorie intake (especially during the first months after surgery) reduces gallbladder contraction, leading to bile stagnation and sludge formation.
- Altered bile acid metabolism: Gastric bypass changes the enterohepatic circulation of bile acids, reducing their concentration in bile and further promoting cholesterol crystallisation.
- Reduced fat intake: Patients often avoid fats post‑operatively, which reduces cholecystokinin release and gallbladder emptying.
How common are gallstones after weight loss surgery?
The incidence of new gallstones after bariatric surgery varies by procedure and study:
- Roux‑en‑Y gastric bypass (RYGB): 10‑30% develop gallstones within 1‑2 years.
- Sleeve gastrectomy: 10‑20% develop gallstones.
- Adjustable gastric banding: 5‑15% (lower risk due to slower weight loss).
- Without prophylaxis, up to 30‑40% of patients develop sludge or stones. Symptomatic stones occur in 5‑10%.
Who is at highest risk?
Certain patients are more likely to develop post‑bariatric gallstones:
- Pre‑existing gallstones or sludge (found in 10‑20% of bariatric candidates).
- Rapid weight loss (greater than 1.5 kg/week).
- Female sex (oestrogen increases cholesterol secretion).
- Higher pre‑operative BMI.
- Roux‑en‑Y gastric bypass (higher risk than sleeve).
- Family history of gallstones.
Ursodeoxycholic acid (UDCA) – the proven prevention
Ursodeoxycholic acid (UDCA) is the most effective pharmacological intervention to prevent gallstones after bariatric surgery. It works by:
- Reducing cholesterol saturation in bile.
- Increasing bile acid pool.
- Promoting gallbladder emptying.
- Dissolving small cholesterol stones that may form.
Evidence: Multiple randomised controlled trials show that UDCA (500‑600 mg/day for 6 months) reduces gallstone incidence by 70‑80% after bariatric surgery. The number needed to treat (NNT) is approximately 6‑8. UDCA is also safe and well tolerated.
UDCA dosing, duration, and side effects
Typical dose: 500‑600 mg daily, divided into two doses (e.g., 250‑300 mg twice daily). Some protocols use 10‑15 mg/kg/day.
Duration: Start immediately after surgery (within 1‑2 weeks) and continue for 6 months. Some guidelines recommend 12 months for high‑risk patients.
Side effects: Generally mild – diarrhoea (5‑10%), nausea, dyspepsia. Rarely, allergic reactions. UDCA is safe and does not interfere with weight loss or nutritional absorption.
Cost: In India, UDCA costs approximately ₹1,500‑3,000 for a 6‑month course – highly cost‑effective compared to treating gallstone complications.
Prophylactic cholecystectomy – when is it recommended?
Prophylactic cholecystectomy (removing the gallbladder at the time of bariatric surgery) is controversial. Current guidelines:
- Routine prophylactic cholecystectomy is not recommended for all bariatric patients, because UDCA is effective and avoids an extra procedure.
- Consider cholecystectomy if:
- Patient has pre‑operative symptomatic gallstones or complications.
- Patient has very large stones (>2‑3 cm) or porcelain gallbladder (increased cancer risk).
- Patient cannot take or adhere to UDCA.
- Patient is undergoing Roux‑en‑Y gastric bypass (some surgeons routinely remove the gallbladder during bypass because the altered anatomy makes future ERCP difficult).
Managing gallstones after bariatric surgery
If a patient develops symptomatic gallstones after bariatric surgery despite UDCA (or if UDCA was not used), management options include:
- Laparoscopic cholecystectomy: Safe after bariatric surgery, but may be technically more difficult due to adhesions and altered anatomy. Ideally performed after weight loss stabilises (6‑12 months post‑op).
- ERCP for common bile duct stones: Can be challenging after gastric bypass (altered anatomy). Many centres use laparoscopic‑assisted ERCP or enteroscopy. Sleeve gastrectomy patients have normal anatomy, so ERCP is standard.
- UDCA alone: For small cholesterol stones (<5‑10mm), UDCA may dissolve them over 6‑12 months, especially if started early.
Interactive FAQ – Gallstones after bariatric surgery
Yes – sleeve gastrectomy carries significant gallstone risk (10‑20%). UDCA for 6 months is recommended unless you had a prior cholecystectomy.
UDCA can be used to dissolve small cholesterol stones (<5‑10mm), but it takes months. Most surgeons prefer cholecystectomy during bariatric surgery if stones are present and symptomatic.
Right upper quadrant pain, nausea, bloating, fat intolerance – similar to non‑surgical patients. However, pain may be less typical due to altered anatomy. Fever or jaundice suggests complications.
Yes – laparoscopic cholecystectomy is safe, though it may be more challenging due to adhesions and intra‑abdominal fat loss. Wait 3‑6 months after bariatric surgery for optimal safety.
No – UDCA does not interfere with weight loss or nutrient absorption. It is a bile acid that is well tolerated.
Just resume your normal dose. Missing a few days does not significantly increase risk, but consistency over 6 months is important for full protection.
Gradual weight loss (not always possible after bariatric surgery), adequate fat intake to stimulate gallbladder contraction, and hydration may help, but UDCA is the only proven prophylaxis.
Risk is lower (5‑15%), but still present. UDCA is often not routinely prescribed for band patients, but consider it for high‑risk individuals (female, family history, rapid loss).
Most Indian health insurance policies cover UDCA if prescribed by a doctor. Check with your insurer. The cost is modest (₹1,500‑3,000 for 6 months).
Disclaimer: This information is for educational purposes. If you are planning or have undergone bariatric surgery, discuss gallstone prevention with your surgeon and gastroenterologist at Vivekananda Hospital.